HEADINGTEST | Merck

Login du candidat

Nous sommes une seule entreprise, mais nous exerçons nos activités sous deux marques différentes : Merck & Co, Inc, Kenilworth, New Jersey, USA aux États-Unis, au Canada et à Porto Rico, et MSD dans le reste du monde.
Entreprise
Recherche et produits
Patients
Carrières
Investisseurs
Médias
Communiquez avec nous
À l’échelle mondiale Pays à l’extérieur des États-Unis et du Canada.

The link you have selected will take you to a third-party website, owned and operated by AgileOne. Our company does not control, and is not responsible for, the accuracy, content, practices, or standards of the pharmatempjobs.com website and/or AgileOne.

Lorem Ipsum H3

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

H44Lorem Ipsum

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Media Overlay Image

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Media Overlay Image

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Media Overlay Image

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

H55Lorum Ipsum

Responsabilité de la société

Rapport sur la responsabilité de la société

Rapport sur notre engagement envers la société, les gens et les communautés du monde entier

Merck pour les mères

Une initiative pour créer un monde où aucune femme ne doit mourir en donnant la vie

À propos de Merck

Groupe Merck Santé animale

Le groupe commercial mondial de santé animale de Merck

Déclarations prospectives
Politique relative aux témoins
Cookie preferences
Confidentialité
Transparence
Conditions d’utilisation du site
Sitemap

© 2009-2021 Merck Sharp & Dohme Corp., filiale de Merck & Co., Inc. Tous droits réservés.

Forward-Looking Statement

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA

This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

160e1b2b7a384b4d96fc79eeedcc6fb8